Passage Bio
Tiffini Voss is a seasoned professional in clinical development, currently serving as Vice President at Passage Bio since July 2021. Previously, Tiffini held the position of Director at Merck from June 2012 to July 2021 and served as an Assistant Professor at the University of Virginia between September 2009 and June 2012. Tiffini's foundation in neurology was established through a fellowship in Movement Disorders and Experimental Therapeutics at the University of Rochester Medical Center from June 2007 to July 2009, following a Neurology Residency at the University of Pennsylvania Health System from June 2003 to June 2007. Tiffini earned a Doctor of Medicine degree from the University of Pennsylvania School of Medicine in 2003 and a Bachelor of Arts in Neuroscience from The Johns Hopkins University in 1999.
This person is not in any offices
Passage Bio
1 followers
Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).